Melissa Hogg (@HoggNDMD) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times - Gastroenterology
Melissa Hogg (@HoggNDMD) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
UPMCSurgicalOncology (@UPMCSurgOnc) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
Dr. Jason Luke, MD – Pittsburgh, PA | Oncology
Melissa Hogg (@HoggNDMD) / Twitter
Tweets with replies by UPMCSurgicalOncology (@UPMCSurgOnc) / Twitter
Jennifer Xavier - Research Associate Professor - University of Pittsburgh | LinkedIn
See Article that... - UPMC Surgical Oncology Services | Facebook
Dr. Melissa Hogg Interviewed for University of Wisconsin Department of Surgery Podcast | Department of Surgery | University of Pittsburgh
Jennifer Xavier - Research Associate Professor - University of Pittsburgh | LinkedIn
UPMC Pancreatic Cancer Center-Pittsburgh PA Archives - SAGES
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma - Fei - 2021 - Clinical and Translational Science - Wiley Online Library
UPMCSurgicalOncology (@UPMCSurgOnc) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
Dr. James P. Ohr, DO | Pittsburgh, PA | Oncologist | US News Doctors
Dr. Matthew P. Holtzman, MD | Pittsburgh, PA | General Surgeon | US News Doctors
Melissa Hogg (@HoggNDMD) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
Melissa Hogg (@HoggNDMD) / Twitter
UPMCSurgicalOncology (@UPMCSurgOnc) / Twitter
UPMCSurgicalOncology (@UPMCSurgOnc) / Twitter
